Valuation: Artivion, Inc.

Market Cap 1.18B 1.03B 966M 882M 1.66B 112B 1.66B 11.6B 4.48B 57.44B 4.42B 4.32B 185B P/E 2026 *
-68.9x
P/E 2027 * 91.1x
Enterprise Value 1.18B 1.03B 966M 882M 1.66B 112B 1.66B 11.6B 4.48B 57.44B 4.42B 4.32B 185B EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.17x
Free-Float
89.42%
Yield 2026 *
-
Yield 2027 * -
1 day+2.12%
1 week-4.93%
Current month-10.60%
1 month-14.07%
3 months+19.87%
6 months-31.66%
Current year-47.09%
1 week 22.92
Extreme 22.92
25.14
1 month 22.92
Extreme 22.92
28.16
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 01/09/2014
Director of Finance/CFO 53 03/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 30/11/2003
Director/Board Member 66 30/11/2003
Director/Board Member 61 30/04/2012
Date Insider Type Main position Quantity % Market Cap. Importance
10/09/26 Sell

General Counsel

-11,480 0.0235%
03/09/26 Sell

General Counsel

-1,493 0.0031%
19/08/26 Sell

Chief Executive Officer

-70,000 0.1442%
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%-4.93%-41.29%+60.44% 1.18B
+0.69%+1.63%-24.10%+5.64% 179B
-1.07%-3.18%-4.07%+13.08% 116B
-0.65%-2.74%+8.88%+69.09% 60B
+1.27%-1.57%-1.90%-31.00% 49.85B
-0.22%+1.23%+7.80%+45.79% 48.05B
+0.40%+3.56%+28.80%+2.32% 33.79B
+7.73%+7.23% - - 30.21B
+2.57%+1.67%+47.13%-0.38% 26.12B
+2.38%+8.63%+11.66%-10.18% 22.98B
Average +1.52%+1.01%+3.66%+17.20% 56.77B
Weighted average by Cap. +0.68%+0.43%-2.91%+13.47%

Financials

2026 *2027 *
Net sales 490M 429M 403M 368M 690M 46.88B 690M 4.83B 1.87B 23.94B 1.84B 1.8B 77.18B 543M 475M 446M 407M 764M 51.93B 764M 5.35B 2.07B 26.52B 2.04B 2B 85.49B
Net income -16.53M -14.45M -13.58M -12.39M -23.26M -1.58B -23.26M -163M -62.89M -807M -62.09M -60.73M -2.6B 11.4M 9.96M 9.36M 8.54M 16.03M 1.09B 16.03M 112M 43.34M 556M 42.79M 41.85M 1.79B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
22/09/26 US$24.13 +2.12% 605,597
21/09/26 US$23.63 +1.20% 569,146
18/09/26 US$23.35 -2.22% 1,914,780
17/09/26 US$23.88 -4.56% 572,581
16/09/26 US$25.02 -1.42% 683,245
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
24.13USD
Average target price
42.15USD
Spread / Average Target
+74.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!